Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.6 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |